EU authorizes Pfizer-BioNTech XFG-adapted COVID vaccine for ages 6 months and up - PFE News | RalliesEU authorizes Pfizer-BioNTech XFG-adapted COVID vaccine for ages 6 months and up
P
PFE• EU grants marketing authorization for updated vaccine
- European Commission granted marketing authorization for Pfizer-BioNTech’s 2026-2027 monovalent COVID-19 vaccine targeting the XFG variant in the EU.
- Clearance covers people aged 6 months and older across all 27 EU member states, Iceland, Liechtenstein, Norway.
- Shipments expected to start soon as manufacturing ramps ahead of the respiratory season.
•
